Posts tagged with: "fda" Results 861 - 880 of 40,590
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Apr 2008, 9:19 am
Article in the Wall Street Journal -- Congress, FDA Debate Foreign Inspections, by Alicia Mundy. [read post]
7 Oct 2010, 1:50 pm by dcooley
In March 2010, the FDA released a report warning users of the potentially “fraudulent” practices associated with internet pharmacies selling medication for pets, such as heartworm preventatives and nonsteroidal anti-inflammatory drugs (NSAIDs). [read post]
5 Sep 2008, 5:54 pm
Article on cnn.com -- FDA warns on arthritis drugs: Government regulators order stronger warnings for four types of arthritis medication, saying they can increase risk of death by infection, by the Associated Press. [read post]
13 Feb 2004, 1:16 am
Two years and two law suits later, the FDA has finally approved ImClone's cancer drug, Erbitux. [read post]
8 May 2009, 9:58 pm
American Conference Institute (ACI) will be holding the next session of its FDA Boot Camp conference on July 21-22, 2009 in Chicago, IL. [read post]
30 Jan 2009, 9:36 pm
American Conference Institute (ACI) will be holding the next session of its FDA Boot Camp conference on March 30-31, 2009 in New York, NY. [read post]
29 Oct 2015, 3:09 pm by Lisa Baird
GAO also reviewed documents, such as FDA guidance, and interviewed FDA officials. [read post]
15 Aug 2018, 11:47 am by The A&M Team
Recall of Valsartan by the FDA Some Blood Pressure Meds Are Being Recalled by the FDA — Here’s What to Know The U.S. [read post]
20 Feb 2023, 9:05 pm by Evelyn Tsisin
Two oncology trials approved by FDA in 2020 reported enrolling zero Black participants. [read post]
12 Jun 2023, 5:00 am by Matthew Chun
On May 10, FDA published a discussion paper on this topic and requested feedback “to enhance mutual learning and to establish a dialogue with FDA stakeholders” and to “help inform the regulatory landscape in this area. [read post]
31 Dec 2014, 7:16 am by Robert Kraft
The Wall Street Journal “Pharmalot” blog reports that the FDA has delayed finalizing a proposed rule that would allow generic drug makers to update safety warnings independently before receiving FDA permission; a right that is currently afforded only to brand-name drug makers. [read post]
9 Nov 2011, 6:14 am by Mark Zamora
The FDA has updated warning  to avoid prescribing either methylene blue or linezolid (Zyvox, Pfizer) in combination with serotonergic agents because of the potential to cause serotonin syndrome.Today, the FDA announced that the risk for this harmful interaction appears to be confined, in general, to 2 specific types of serotonergic drugs: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors.Methylene blue is a dye used in diagnostic… [read post]
4 May 2012, 7:39 am by James R. Denlea
  Further, the FDA has reported that in March, two Army soldiers, who reportedly took DMAA products, died unexpectedly during fitness exercises. [read post]
29 Jan 2008, 7:47 am
The New York Times quotes Peter Barton Hutt, a former top lawyer with the FDA who will testify Tuesday before the House Energy and Commerce committee:"This is a fundamentally broken agency, and it needs to be repaired. [read post]
1 Oct 2020, 9:00 am by Staff
FDA also requires that you substantiate your claims and have safe ingredients The post FDA Warning Letters Can Cause Cosmetic Companies to Lose Revenue and Face Substantial Fines appeared first on Cohen Healthcare Law Group | Healthcare Lawyers | FDA & FTC Law. [read post]